Patients with AML and an IDH2-R172 mutation exhibit a unique initial response to intensive chemotherapy induction

Patients with AML and an IDH2-R172 mutation exhibit a unique initial response to intensive chemotherapy induction

Abstract: The utility of a midcycle bone marrow biopsy (BMB) for early assessment of response in patients with acute myeloid leukemia (AML) after intensive chemotherapy (IC) induction is contested. Even when challenged, there is little consideration as to the possibility of different response dynami...

Full description

Saved in:
Bibliographic Details
Main Authors: Meira Yisraeli Salman, Alexander R. Terry, Andriy Derkach, David Nemirovsky, Kuo-Kai Chin, Yannis K. Valtis, Leora Boussi, Theresa Spivey, Wenbin Xiao, Christopher Famulare, Jenna Ciervo, Jacob M. Rowe, Martin S. Tallman, Eytan M. Stein
Format: Article
Language:English
Published: Elsevier 2025-07-01
Series:Blood Advances
Online Access:http://www.sciencedirect.com/science/article/pii/S2473952925002071
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items